SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
BioLineRx Ltd. Announces BL-8040, for the Treatment of Leukemia and Other Types of Hematological Cancer, to be Presented at 2012 American Society of Hematology Annual Meeting